Emergex Vaccines

Developer T-cell Vaccines for treating viral and bacterial infections

placeAbingdon, England, United Kingdom calendar_todayFounded 2016 groups19 employees language emergexvaccines.com

Registered entities

Investor mix

15 investors on record; lead investors include Vickers Venture Partners.

Investor typeCountShare
Venture capital213%
Other / undisclosed1387%
Coming soon